At a glance
ClinicalIndex Comparison RecordN/ACompleted· 112 enrolled
Drug / intervention
Active NeuroStar® Transcranial Magnetic Stimulation (TMS) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Sham-Controlled Trial Evaluating the Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents
In Brief
A clinical study evaluating Active NeuroStar® Transcranial Magnetic Stimulation (TMS) and Sham NeuroStar® Transcranial Magnetic Stimulation (TMS) for Major Depressive Disorder. Completed, enrolled 112 participants across 13 sites.
Detailed Summary
To evaluate the safety and efficacy of daily, active Neurostar® TMS (when compared with sham treatment) in adolescents meeting criteria for Major Depressive Disorder (MDD).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMajor Depressive Disorder
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartOct 2015
First PostedOct 2015
Primary CompletionJan 2018
Study CompletionDec 2018
TodayJul 2026
First PostedOct 26, 2015
Enrollment StartOct 1, 2015
Primary CompletionJan 1, 2018
Study CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 10.7 years ago
Interventions
Active NeuroStar® Transcranial Magnetic Stimulation (TMS)device
Compare active NeuroStar® coil with sham NeuroStar® coil.
Sham NeuroStar® Transcranial Magnetic Stimulation (TMS)device
Compare active NeuroStar® coil with sham NeuroStar® coil.